Efficient Bayesian Detection of Disease Onset in Truncated Medical Data

Details

08/26/2017, UT USA. Date of Talk: 08/23/2017

Speakers

Marzieh Nabi Abdolyousefi
Event

Efficient Bayesian Detection of Disease Onset in Truncated Medical Data

This paper describes a principled statistical method of preprocessing incidentally collected electronic medical records to facilitate short-term predictions of disease onset without explicit interaction with patients (e.g., medical tests, question- naires). The model is also applicable to detection of remission. In incidentally collected data, records are possibly left and right truncated the first time an event of interest is seen in a patients data may not be the first time in the patients history that it happened. It is therefore difficult to know if a disease onset happens in a given history. If we are unable to determine if and when the onset occurs, supervised learning and regression approaches cannot be applied. Our method determines if an onset occurs in a set of sparse and incomplete patient records, calculates the time of this onset and provides a principled measure of confidence. It combines individual patient history with expectations computed from a reference population. We compare the proposed method against standard change detection algorithms on generated data with realistic event sparsity and show that it can reliably detect onsets where traditional methods fail. We then go on to apply the algorithm to a large corpus of U.S. Medicare data and show that the algorithm scales to large data sets efficiently. The algorithm is currently in trials at a large medical informatics company.

Additional information

Focus Areas

Our work is centered around a series of Focus Areas that we believe are the future of science and technology.

FIND OUT MORE
Licensing & Commercialization Opportunities

We’re continually developing new technologies, many of which are available for Commercialization.

FIND OUT MORE
News

PARC scientists and staffers are active members and contributors to the science and technology communities.

FIND OUT MORE